Is antibody screening in Rh (D)-positive pregnant women necessary?

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 14, Issue 6, 2003, Pages 404-406

  Lurie, S ^a,b,c   Eliezer, E ^a   Piper, I ^a,c   Woliovitch, I ^a  

^a 'Netka'   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c WOLFSON MEDICAL CENTER   (Israel)

Author keywords

Irregular antibodies; Pregnancy; Prenatal care; RH (D); Rhesus system

Indexed keywords

ALLOANTIBODY; BLOOD GROUP ANTIBODY; RHESUS D ANTIBODY;

ANTIBODY SCREENING; ARTICLE; BLOOD GROUP A; BLOOD GROUP AB; BLOOD GROUP B; BLOOD GROUP O; BLOOD GROUP RHESUS SYSTEM; FEMALE; HUMAN; NEWBORN HEMOLYTIC DISEASE; NORMAL HUMAN; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; RHESUS INCOMPATIBILITY;

ANTIBODIES; BLOOD GROUPING AND CROSSMATCHING; DIAGNOSTIC TESTS, ROUTINE; ERYTHROBLASTOSIS, FETAL; FEMALE; HUMANS; ISRAEL; MEDICAL RECORDS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; RH-HR BLOOD-GROUP SYSTEM; UNNECESSARY PROCEDURES;

EID: 0346880094     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.1080/14767050412331312260     Document Type: Article

References (16)

1. Bowman J. The management of hemolytic disease in the fetus and newborn. Semin Perinatol 1997;21:39-44
2. Finn R, Clarke CA, Donohoe WTA, et al. Experimental studies on the prevention of Rh haemolytic diseases. Br Med J 1961;1:1486-90
3. Freda BJ, Gorman JC, Pollack W. Successful prevention of experimental Rh sensitization in man with anti-Rh gamma-globulin antibody preparation: a preliminary report. Transfusion 1964;4:26-32
4. Joseph KS, Kramer MS. The decline in Rh hemolytic disease: should Rh prophylaxis get all credit? Am J Public Health 1998;88:209-15
5. Weinstein L. Irregular antibodies causing hemolytic disease of the newborn: a continuing problem. Clin Obstet Gynecol 1982;25:321-32
6. Daniels GL. Low frequency antigens associated with Rh: markers for genetic variants. Biotest Bull 1997;5:399-407
7. Bowell PJ, Allen DL, Entwistle CC. Blood group antibody screening tests during pregnancy. Br J Obstet Gynaecol 1986; 93:1038-43
8. Andersen AS, Praetorius L, Jorgensen HL, et al. Prognostic value of screening for irregular antibodies late in pregnancy in rhesus positive women. Acta Obstet Gynecol Scand 2002;81:407-11
9. Rothenberg JM, Weirermiller B, Dirig K, et al. Is a third-trimester antibody screen in Rh+ women necessary? Am J Manag Care 1999;5:1145-50
10. Lurie S, Rotmensch S, Glezerman M. Prenatal management of women who have partial Rh (D) antigen. Br J Obstet Gynaecol 2001;108:895-7
11. Lurie S, Yahalom V, Woliovitch I, et al. Partial Rh (D) category Ivb antigen in a pregnant woman: a case report. Isr J Obstet Gynecol 2000;11:59-61
12. Levene C, Medalie JH, Friedlander Y, et al. The distribution of ABO, MNSs, Rhesus, Kell, Duffy and Kidd blood groups of Jews originating from 20 countries. Isr J Med Sci 1984;20:509-18
13. Wagner FF, Kasulke D, Kerowgan M, et al. Frequencies of the blood groups ABO, Rhesus, D category VI, Kell, and of clinically relevant high-frequency antigens in southwestern Germany. Infusionsther Transfusionsmed 1995;22: 285-90
14. Biale Y, Dvilansky A. Management of pregnancies with rare blood types. Acta Obstet Gynecol Scand 1982;61:219-21
15. Cunningham FG, Gant NF, Leveno KJ, et al. Williams Obstetrics, 21st edn. New York: McGraw-Hill, 2001:1057-61
16. Appelman Z, Lurie S, Yuster A, et al. Severe hemolyticdisease of newborn due to anti-c. Int J Gyn Obstet 1990;33:73-5